[vc_row][vc_column][vc_column_text]Immunotherapy is changing cancer as we know it. Experts predict that in just 10 years, immunotherapy will form the backbone for over 60% of cancer treatments, as opposed to less than 3% today.
As the cancer treatment landscape shifts from traditional to immune-targeted therapies, it’s important to understand the benefits and limitations of each approach. By examining the faces of immunotherapy, we can best understand how immunotherapy is changing the world.
Continue reading “New Faces of Immunotherapy”